Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
151.7 USD | -0.39% | +0.69% | -20.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.93% | 19.26B | |
+25.04% | 46.71B | |
+48.83% | 41.8B | |
-0.97% | 41.52B | |
-5.86% | 29.55B | |
+10.33% | 25.78B | |
+1.94% | 12.14B | |
-2.76% | 12.08B | |
+27.82% | 11.98B | |
+20.16% | 11.58B |
- Stock Market
- Equities
- ALNY Stock
- News Alnylam Pharmaceuticals, Inc.
- Alnylam Pharmaceuticals Says Phase 2 Study of Hypertension Drug Zilebesiran Meets Primary Endpoint